There is no specific treatment in the event of TALZENNA overdose, and symptoms of overdose are not established. In the event of overdose, treatment with TALZENNA should be stopped, and physicians should consider gastric decontamination, follow general supportive measures and treat symptomatically.
For management of a suspected drug overdose, contact your regional poison control centre.
There is no specific treatment in the event of TALZENNA overdose, and symptoms of overdose are not established. In the event of overdose, treatment with TALZENNA should be stopped, and physicians should consider gastric decontamination, follow general supportive measures and treat symptomatically.
For management of a suspected drug overdose, contact your regional poison control centre.
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: 1 866 723-7111.
To report an adverse event related to COMIRNATY, and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.